RxDoctor Payments Data

Angela Damiano

Otolaryngology · Keene, NHNPI 1518074822

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Johnson & Johnson at 46.3% of the total. Reporting peaked in 2019 at $496 and has fallen 95.3% since, to $24 in 2025.

$1,530in general payments, 2019–2025

Across 33 payments — averaging $46.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$708
  • Smith+Nephew$190
  • Intersect ENT, Inc.$159
  • Medical Device Business Services, Inc.$125
  • GSK$85
  • Inspire Medical Systems, Inc.$70
  • plus $192 from 6 others

What the payments were for

  • Food & beverage$1,530100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,530 in reported general payments places this provider in the 75th percentile of 44 otolaryngology providers in New Hampshire.

See all otolaryngology providers in New Hampshire

Medicare billing

Part B allowed, 2024
$71,882
Medicare patients
287
Services billed
554

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth27$2,459
Fluticasone Propionate102$1,568
Ipratropium Bromide23$688
Azelastine Hcl14$453
Desloratadine18$401
Montelukast Sodium32$262
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$180

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Keene

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →